Articles

Indy without Lilly, the 500?

An Indiana University prof thinks Indianapolis should anticipate a future without Indianapolis Motor Speedway, and a potentially
reduced Eli Lilly and Co.

Read More

City of Greenwood might fund launch of insulin maker

Greenwood-based Zimmerman Biotechnologies LLC hopes to become the first company in the United States to make generic insulin,
a long-awaited development in diabetes treatment. The Greenwood Common Council on Feb. 1 will consider an $8.4 million deal
that would finance construction of an insulin factory, as well as help Zimmerman with FDA-approval and equipment expenses.

Read More

EnerDel in line for $3 million grant

Battery maker EnerDel could land $3 million in federal disaster-recovery money that would help bring 200 more jobs to its
facilities on the north side of Indianapolis and in Noblesville.

Read More

Finish Line forfeits incentive deal

Mall retailer The Finish Line Inc. has agreed to forfeit a potentially lucrative tax-abatement deal because it won’t be able
to meet a 2008 promise to create almost 200 jobs and invest $24 million at its Indianapolis headquarters.

Read More